lu 135252 has been researched along with Arrhythmias, Cardiac in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrási, T; Gellér, L; Juhász-Nagy, A; Kékesi, V; Merkely, B; Soós, P; Szabó, T; Vágó, H; Zima, E | 1 |
| Gellér, L; Kiss, O; Merkely, B; Szabó, T; Vágó, H; Zima, E | 1 |
| Gellér, L; Horkay, F; Juhász-Nagy, A; Kiss, O; Merkely, B; Raschack, M; Szabó, T | 1 |
| Gellér, L; Horkay, F; Juhász-Nagy, A; Kiss, O; Merkely, B; Raschack, M; Seres, L; Szabó, T; Zima, E | 1 |
4 other study(ies) available for lu 135252 and Arrhythmias, Cardiac
| Article | Year |
|---|---|
The ET(A) receptor antagonist LU 135252 has no electrophysiological or anti-arrhythmic effects during myocardial ischaemia/reperfusion in dogs.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Dogs; Endothelin Receptor Antagonists; Models, Animal; Myocardial Reperfusion; Myocardial Reperfusion Injury; Phenylpropionates; Pyrimidines; Receptor, Endothelin A | 2002 |
Arrhythmogenic action of endothelin-1.
Topics: Animals; Arrhythmias, Cardiac; Dogs; Drug Administration Schedule; Endothelin Receptor Antagonists; Endothelin-1; Myocardial Ischemia; Phenylpropionates; Pyrimidines; Receptor, Endothelin A | 2000 |
The selective endothelin-A-receptor antagonist LU 135.252 inhibits the direct arrhythmogenic action of endothelin-1.
Topics: Animals; Arrhythmias, Cardiac; Dogs; Endothelin Receptor Antagonists; Endothelin-1; Phenylpropionates; Pyrimidines; Receptor, Endothelin A | 2000 |
Endothelin-A-receptor antagonist LU 135.252 inhibits the formation of ventricular arrhythmias caused by intrapericardial infusion of endothelin-1.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Dogs; Endothelin Receptor Antagonists; Endothelin-1; Hemodynamics; Phenylpropionates; Pyrimidines; Receptor, Endothelin A | 2000 |